Edit |   |
---|---|
Antigenic Specificity | IL13, Human (Anrukinzumab biosimilar) |
Clone | Anrukinzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FuncS, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL13 Recombinant Antibody (Anrukinzumab). Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma. Anrukinzumab was developed by Wyeth. |
Immunogen | n/a |
Other Names | Anti-IL13 Recombinant Antibody, Research Grade Anrukinzumab, Anti-Human IL13 Recombinant Antibody(Anrukinzumab), IMA-638, Antibody Drug Analogues, Monoclonal Antibody, YR1148, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 910649-32-0 |
Catalog # | YR1148 |
Price | please inquire |
Order / More Info | IL13, Human (Anrukinzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |